| Original language | American English |
|---|---|
| Journal | Annals of Oncology |
| State | Published - 2020 |
Disciplines
- Medicine and Health Sciences
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
A Phase I, First-in-Human, Safety, Pharmacokinetic, and Pharmacodynamic Study of Oral Dubermatinib (TP-0903) in Patients with Advanced Solid Tumours.
- Bruno Bastos
Research output: Contribution to journal › Article › peer-review